Skip to main content
64°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
This Company Revolutionizes What Matters for Hospitals, Big Pharma and Health Insurers
October 14, 2021
Tickers
ABBV
BMY
GILD
JNJ
Tags
RHHBY
Market News
Healthcare Triangle
From
Benzinga
Is AstraZeneca Set to Soar With an Advanced Breast Cancer Treatment?
October 14, 2021
Tickers
AZN
RHHBY
Tags
RHHBY
AZN
Market News
From
Motley Fool
The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts
October 14, 2021
Tickers
CBIO
CRSP
FBIO
IPOS
Tags
MRNA
News
CBIO
From
Benzinga
Never Mind Ginkgo Bioworks' Drama -- This Synthetic Biology Stock Is Still a Buy
October 13, 2021
Tickers
AMRS
DNA
RHHBY
TGT
Tags
DNA
WBA
Market News
From
Motley Fool
3 COVID Stocks That Can Turn $1,000 Into $10,000
October 12, 2021
Tickers
AVIR
DOCS
FB
ILMN
Tags
PFE
ILMN
MSFT
From
Motley Fool
Sarepta's Duchenne Gene Therapy Shows Sustained Functional Improvements
October 11, 2021
Tickers
RHHBY
SRPT
Tags
Trading Ideas
Phase 3 Trial
Biotech
From
Benzinga
4 Key Things Investors Should Know About Pfizer's Experimental COVID-19 Pill
October 11, 2021
Tickers
AVIR
MRK
PFE
RHHBY
Tags
Market News
MRK
AVIR
From
Motley Fool
Roche's Alzheimer's Candidate Secures FDA Breakthrough Designation
October 08, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Benzinga
FDA
FDA Breakthrough Designation
From
Benzinga
Can This Duo Outperform Merck and Ridgeback Biotherapeutics' COVID Treatment?
October 08, 2021
Tickers
AVIR
MRK
MRNA
NVAX
Tags
AVIR
NVAX
MRNA
From
Motley Fool
Merck's Oral COVID-19 Treatment Could Be Game-Changer: BofA Analyst
October 06, 2021
Tickers
BNTX
JNJ
MRK
MRNA
Tags
BofA Securities
PFE
Geoff Meacham
From
Benzinga
Moderna Is Down 12%. Is It Time to Buy?
October 06, 2021
Tickers
MRK
MRNA
RHHBY
Tags
Market News
MRK
MRNA
From
Motley Fool
Why Novavax Stock Plunged in September
October 06, 2021
Tickers
AVIR
BNTX
MRNA
NVAX
Tags
AVIR
NVAX
BNTX
From
Motley Fool
Which COVID-19 Pill Stock Is the Best Buy?
October 05, 2021
Tickers
AVIR
BNTX
MRK
PFE
Tags
AVIR
PFE
RHHBY
From
Motley Fool
2 Best Biotech Stocks to Buy In October
October 04, 2021
Tickers
AVIR
IBB
MRK
OCGN
Tags
AVIR
XBI
IBB
From
Motley Fool
3 Stocks That Might Soar With Pills for COVID
October 03, 2021
Tickers
AVIR
MRK
MRNA
NVAX
Tags
AVIR
NVAX
REGN
From
Motley Fool
Here Are the Leaders in the Race to Develop a COVID-19 Pill
October 03, 2021
Tickers
AVIR
MRK
PFE
RDHL
Tags
Market News
MRK
REGN
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
October 01, 2021
Tickers
ANIP
AVDL
BHC
CALT
Tags
Top Stories
SNY
GMAB
From
Benzinga
Labcorp's At Home Collection Kit Gets EUA Nod For Combined COVID-19 and Flu Detection
October 01, 2021
Tickers
LH
RHHBF
RHHBY
RHHVF
Tags
FDA
Benzinga
COVID/19 Coronavirus
From
Benzinga
BioNTech Starts Dosing In Mid-Stage Colorectal Cancer Immunotherapy Trial
October 01, 2021
Tickers
BNTX
RHHBF
RHHBY
RHHVF
Tags
Benzinga
Biotech
Trading Ideas
From
Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Tickers
ABBV
ADMA
AGTC
AIM
Tags
HLTH
XBIT
XLRN
From
Benzinga
Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail
September 30, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
News
Health Care
RHHBY
From
Benzinga
3 COVID Stocks Ready to Take On the Delta Variant
September 27, 2021
Tickers
BNTX
GILD
LLY
NVAX
Tags
GILD
PFE
RHHBY
From
Motley Fool
Glaxo - Vir Biotech's COVID Treatment Approved In Japan
September 27, 2021
Tickers
GSK
REGN
RHHBF
RHHBY
Tags
RHHBF
Market News
News
From
Benzinga
3 Biotech Stocks That Could Make You Filthy Rich
September 27, 2021
Tickers
ADAP
AMGN
AZN
CHGCY
Tags
VSTM
AZN
NVAX
From
Motley Fool
Acceleron In Advanced $11B Buyout Talks: Bloomberg
September 27, 2021
Tickers
AMGN
BMY
GILD
MRK
Tags
News
M&A
RHHBY
From
Benzinga
September Sell-Off Alert: Buy Vertex Pharmaceuticals on the Dip
September 25, 2021
Tickers
CRSP
NDAQ
RHHBY
VRTX
Tags
VRTX
Market News
CRSP
From
Motley Fool
Roche Builds Case For Evrysdi Benefits In Younger Spinal Muscular Atrophy Patients
September 24, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Spinal Muscular Atrophy
General
Biotech
From
Benzinga
WHO Backs Regeneron COVID-19 Antibody Cocktail As It Calls For Equal Access
September 24, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Biotech
Benzinga
Government
From
Benzinga
Here's Why Everyone's Talking About AstraZeneca Right Now
September 21, 2021
Tickers
AZN
DSNKY
RHHBY
Tags
RHHBY
Market News
AZN
From
Motley Fool
AstraZeneca's Enhertu Posts Substantial Clinical Benefit Over Roche's Kadcyla In Breast Cancer Trials
September 20, 2021
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
News
Long Ideas
RHHBY
From
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.